AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|
25 C
New York
Saturday, August 1, 2026

Tag: revenues

newssourceFORcompanyinformationcontent1releasesmarket

Eos Energy Successfully Closed $336M in Concurrent Offerings of Common Stock and Convertible Senior Notes, Strengthening its Balance Sheet and Creating Enhanced Financial Flexibility

Simplified capital structure bolsters ability to rapidly meet customer demand, reduce interest expense, and increase liquidity

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4...

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints

Airbus and McGill University are driving innovation in aerospace with an agreement for experiential learning and research

The initiative will help further propel Quebec and Canadian aerospace on the world stage, thus strengthening Montréal's position as one of the major international...

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

               

A TRANSFORMATIVE YEAR FOR VIA RAIL AMID ONGOING OPERATIONAL CHALLENGES

HIGHLIGHTS ...

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device Regulation (MDR) for the CGuard® Prime EPS.

Coffee Holding Co., Inc. Reports Second Quarter Results and New Dividend.

STATEN ISLAND, New York, June 13, 2025 (GLOBE NEWSWIRE) -- Coffee Holding Co., Inc. (Nasdaq: JVA) (the “Company,” “our” or “we”) announced its operating results for the fiscal quarter ended April 30, 2025.

Funeral Homes: Strategic Innovation Required Amid Shifting Consumer Preferences

The current landscape of the funeral service industry is encountering significant changes, primarily driven by the rising trend in cremation rates. According to recent...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRevenues

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers